MGMT and neoplasm: Prognostic factors, including age, tumor size, feasibility of achieving complete tumor removal, O6-methylguanine-DNA methyltransferase (MGMT) methylation status, and particularly IDH mutation (more prevalent in secondary glioblastomas), markedly influence patient prognosis [5].